OTUD1 Knockout HAP1 Cell Line
Cat.No.:
EDC08210
Species:
Human
Cell Name:
HAP1
Gene:
OTUD1
Gene ID:
220213
Size:
1×10⁶cells
OTUD1 Knockout HAP1 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08210 |
|---|---|
| Product Name | OTUD1 Knockout HAP1 Cell Line |
| Species | Human |
| Cell Line | HAP1 |
| Cellosaurus ID | CVCL_0F62 |
| Cell Line Synonyms | Highly Aggressively Proliferating Immortalized |
| Gene ID | |
| Gene | OTUD1 |
| Summary |
Deubiquitinating enzymes (DUBs; see MIM 603478) are proteases that specifically cleave ubiquitin (MIM 191339) linkages, negating the action of ubiquitin ligases. DUBA7 belongs to a DUB subfamily characterized by an ovarian tumor (OTU) domain.[supplied by OMIM, May 2008]
|
| Digestion Time | 2 min |
| Morphology | Adherent |
| Passage Ratio | 1:8~1:10 |
| Complete Culture Medium | IMDM+10%FBS |
| Freezing Medium | 90%FBS+10%DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
FAQ
Which is better for studying OTUD1 function, OTUD1 Knockout HAP1 Cell Line or OTUD1 overexpression HAP1 Cell Line?
The choice depends on whether you are studying OTUD1's role as a K63-linkage-specific deubiquitinase (DUB) or its functions in immune signaling and DNA damage response. The Knockout line is the standard tool for asking whether OTUD1 is required for K63 polyubiquitin removal — OTUD1 is an ovarian tumor (OTU) family DUB with preference for K63-linked ubiquitin chains and emerging roles in innate immunity (RIG-I, MAVS deubiquitination) and tumor suppression. Overexpression is useful for studying OTUD1 in immune signaling or DDR contexts.
For deubiquitinase research, the EDITGENE OTUD1 Knockout in HAP1 enables study of K63 polyubiquitin biology and OTUD1-specific substrate dephosphorylation patterns. Rescue with wild-type or catalytically-dead (C320A active site cysteine) OTUD1 is the standard specificity control. The knockout is valuable for studying RNA virus-induced innate immunity given OTUD1's negative regulation of RIG-I-MAVS signaling.
What are the application scenarios for this model?
Primary applications:
• K63 polyubiquitin substrate analysis: ubiquitin remnant proteomics in the OTUD1-null context to identify OTUD1-dependent K63 polyubiquitin substrates.
• Innate immunity: RIG-I and MAVS K63 polyubiquitination analysis given OTUD1's negative regulation of antiviral signaling.
• DUB selectivity profiling: in vitro DUB activity assays with diubiquitin chains of different linkages to confirm K63 preference.
• DUB inhibitor specificity: critical genetic control for OTU-family DUB inhibitors in development.
EDITGENE recommends this model for researchers investigating K63-linked polyubiquitin biology and OTUD1-specific deubiquitinase functions.
Is this OTUD1 Knockout HAP1 Cell Line compatible with overexpression rescue experiments?
Yes. OTUD1 rescue experiments require attention to DUB catalytic architecture:
• Construct design: use a codon-modified OTUD1 sequence with a small C-terminal tag (FLAG, HA). OTUD1 has N-terminal serine-rich region and C-terminal OTU catalytic domain with C/H/D triad — preserve all elements.
• Catalytically-dead rescue: C320A active site cysteine mutation abolishes deubiquitinase activity and is the standard specificity control.
• Functional readout: rescue should restore K63 polyubiquitin removal from substrates and downstream signaling attenuation.
HAP1-specific considerations:
• Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay.
• Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended.
• Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download